Fundz Deep Dive
Everything you need to win Orbis Medicines — in one platform.
Who to reach, what to say, and why now on Orbis Medicines — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Orbis Medicines — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Orbis Medicines and Vivtex Form Research & Exclusive Licensing Collaboration for Next-Generation Orally Dosable ‘nCycles'
Contract Type
partnership
Description
Orbis Medicines and Vivtex have formed a research collaboration and option to an exclusive license. The collaboration will enable Orbis to utilize Vivtex’s GI-ORIS™ platform for gut permeability screening to evaluate the oral bioavailability of Orbis’ portfolio of next-generation macrocycle drugs called ‘nCycles’. This partnership aims for faster development of high-quality candidates for clinical entry and bringing a new generation of macrocycle drugs to patients.